BPWM
MESO

BCS Private Wealth Management’s Mesoblast MESO Stock Holding History

BCS Private Wealth Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Hold
16,000
– – 0.07% 176
2026
Q1 		$246K Hold
16,000
– – 0.07% 165
2025
Q4 		$289K Buy
+16,000
New +$275K 0.1% 146

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

BCS Private Wealth Management's MESO Position: Q2 2026 in Review

BCS Private Wealth Management held its Mesoblast (MESO) position steady in Q2 2026 at 16,000 shares worth $216K. The position accounts for 0.07% of the portfolio, ranked #176.

BCS Private Wealth Management first reported a position in MESO in Q4 2025 and has held it in 3 quarters since. The position peaked at $289K in Q4 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • BCS Private Wealth Management held 16,000 shares of Mesoblast worth $216K as of Q2 2026.
  • BCS Private Wealth Management left its Mesoblast share count unchanged in Q2 2026.
  • Mesoblast made up 0.07% of BCS Private Wealth Management's portfolio in Q2 2026, its #176 holding.
  • BCS Private Wealth Management first reported a position in Mesoblast in Q4 2025 and has held it in 3 quarters since.
  • BCS Private Wealth Management's Mesoblast position peaked at $289K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.